IL11 and non-small cell lung carcinoma: Even in late stage III and IV NSCLC patients, Agulló-Ortuño et al. found considerably low plasma IL11 levels of 12.24 pg/mL and 10.60 pg/mL in LUAD and SCC respectively [96], which may require more sensitive assay methods for accurate assessment.